Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | acetylcholinesterase (Yt blood group) | Starlite/ChEMBL | References |
Equus caballus | Butyrylcholinesterase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Onchocerca volvulus | Butyrylcholinesterase | 602 aa | 578 aa | 25.4 % | |
Echinococcus multilocularis | neuroligin | Butyrylcholinesterase | 602 aa | 493 aa | 26.0 % |
Echinococcus multilocularis | BC026374 protein (S09 family) | Butyrylcholinesterase | 602 aa | 636 aa | 34.9 % |
Loa Loa (eye worm) | hypothetical protein | Butyrylcholinesterase | 602 aa | 573 aa | 26.2 % |
Onchocerca volvulus | Carnitine O-palmitoyltransferase 2, mitochondrial homolog | Butyrylcholinesterase | 602 aa | 554 aa | 35.9 % |
Schistosoma mansoni | gliotactin | Butyrylcholinesterase | 602 aa | 587 aa | 28.1 % |
Drosophila melanogaster | CG10175 gene product from transcript CG10175-RE | Butyrylcholinesterase | 602 aa | 547 aa | 29.4 % |
Onchocerca volvulus | Molybdopterin synthase catalytic subunit homolog | Butyrylcholinesterase | 602 aa | 560 aa | 29.3 % |
Onchocerca volvulus | Butyrylcholinesterase | 602 aa | 587 aa | 27.1 % | |
Loa Loa (eye worm) | hypothetical protein | Butyrylcholinesterase | 602 aa | 574 aa | 26.3 % |
Echinococcus granulosus | BC026374 protein S09 family | Butyrylcholinesterase | 602 aa | 649 aa | 34.2 % |
Onchocerca volvulus | Butyrylcholinesterase | 602 aa | 551 aa | 30.1 % | |
Echinococcus granulosus | neuroligin | Butyrylcholinesterase | 602 aa | 492 aa | 24.2 % |
Onchocerca volvulus | Putative nuclear protein | Butyrylcholinesterase | 602 aa | 573 aa | 41.4 % |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | Butyrylcholinesterase | 602 aa | 590 aa | 25.3 % |
Brugia malayi | Carboxylesterase family protein | Butyrylcholinesterase | 602 aa | 549 aa | 29.5 % |
Brugia malayi | Carboxylesterase family protein | acetylcholinesterase (Yt blood group) | 614 aa | 510 aa | 26.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.0343 | 0.0343 |
Echinococcus multilocularis | bifunctional protein NCOAT | 0.0533 | 1 | 1 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0036 | 0.0163 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0233 | 0.4055 | 0.4055 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.0343 | 0.0343 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0036 | 0.0163 | 0.5 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.0163 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0164 | 0.2693 | 0.2693 |
Echinococcus granulosus | bifunctional protein NCOAT | 0.0533 | 1 | 1 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.0163 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0047 | 0.0391 | 0.0391 |
Onchocerca volvulus | 0.0047 | 0.0391 | 0.213 | |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0036 | 0.0163 | 0.0163 |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 0.4055 | 0.4055 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.0163 | 0.5 |
Schistosoma mansoni | aminopeptidase P homologue (M24 family) | 0.0533 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.012 | 0.1837 | 0.1837 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.2693 | 0.2693 |
Echinococcus multilocularis | acetylcholinesterase | 0.0164 | 0.2693 | 0.2693 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0032 | 0.0088 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0233 | 0.4055 | 0.4055 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.2693 | 0.2693 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.0343 | 0.0343 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.0343 | 0.0343 |
Schistosoma mansoni | inositol monophosphatase | 0.0036 | 0.0163 | 0.0163 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.0343 | 0.0343 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0164 | 0.2693 | 0.2693 |
Loa Loa (eye worm) | carboxylesterase | 0.0164 | 0.2693 | 0.2693 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0036 | 0.0163 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0164 | 0.2693 | 0.2693 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.1837 | 0.1837 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0032 | 0.0088 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.2693 | 0.2693 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.1837 | 0.1837 |
Echinococcus multilocularis | acetylcholinesterase | 0.0164 | 0.2693 | 0.2693 |
Brugia malayi | Inositol-1 | 0.0036 | 0.0163 | 0.0163 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0036 | 0.0163 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.0391 | 0.0391 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0036 | 0.0163 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.0343 | 0.0343 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.0343 | 0.0343 |
Schistosoma mansoni | survival motor neuron protein | 0.0047 | 0.0391 | 0.0391 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.0343 | 0.0343 |
Loa Loa (eye worm) | hypothetical protein | 0.0226 | 0.3933 | 0.3933 |
Brugia malayi | hypothetical protein | 0.0233 | 0.4055 | 0.4055 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.0163 | 0.5 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0036 | 0.0163 | 1 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0164 | 0.2693 | 0.2693 |
Schistosoma mansoni | inositol monophosphatase | 0.0036 | 0.0163 | 0.0163 |
Schistosoma mansoni | Hyaluronidase | 0.0533 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.2693 | 0.2693 |
Echinococcus granulosus | acetylcholinesterase | 0.0164 | 0.2693 | 0.2693 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0036 | 0.0163 | 0.0163 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.0343 | 0.0343 |
Echinococcus granulosus | carboxylesterase 5A | 0.0164 | 0.2693 | 0.2693 |
Loa Loa (eye worm) | hyaluronidase | 0.0533 | 1 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.012 | 0.1837 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.012 | 0.1837 | 1 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0036 | 0.0163 | 0.5 |
Loa Loa (eye worm) | inositol-1 | 0.0036 | 0.0163 | 0.0163 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.86 uM | In vitro inhibitory concentration against purified Acetylcholinesterase of human erythrocytes; value ranges from 0.76-1.05 | ChEMBL. | 12431053 |
IC50 (binding) | = 6.4 uM | In vitro inhibitory concentration against Butyrylcholinesterase of horse serum; value ranges from 4.9-11.2 | ChEMBL. | 12431053 |
IC50 (binding) | = 500 uM | In vitro inhibitory concentration against Monoamine oxidase B of rat brain homogenates; value ranges from 260-1100 | ChEMBL. | 12431053 |
IC50 (binding) | = 700 uM | In vitro inhibitory concentration against Monoamine oxidase A of rat brain homogenates; value ranges from 540-850 | ChEMBL. | 12431053 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.